Novavax to partner with SII(Serum Institute Of India)
In spite of clearing the Efficacy Test with a score of 90.4%, novavax has uncertainty for authorization in the US. But India appears as the major destination for this shot.…
“Never exported vaccines at the cost of the people of India”, says Adar Poonawalla
The Serum Institute of India company exported covid-19 across only when the health experts believe that the country was “turning the tide on the pandemic” said the CEO of SII…
From August 2021 Biological E to begin producing 75-80 million doses of vaccine candidate
From August 2021, vaccine manufacturer Biological E is preparing to produce 75-80 million doses per month of its recombinant protein vaccine candidate. The company also said its vaccine is going…
Relief Measures announced by RBI for Vaccine Manufacturers, Healthcare Sector, Individual Borrowing and Small Businesses
On Wednesday, in response to the second wave of a covid-19 pandemic, the RBI announced relief measures taken for vaccine manufacturers, the healthcare sector, individual borrowing, and small businesses. Shaktikanta…
Serum’s Institute (SII) To Invest £240 million IN UK as a Part of India-UK partnership
As a part of India-UK, an enhanced trade partnership held virtually between Prime Minister Narendra Modi and Prime Minister Borris Johnson. The Indian companies will invest £1 billion for creating…
Centre asks vaccine manufacturers SII, Bharat Biotech to lower COVID-19 vaccine price
On Monday, the central government has asked the Bharat Biotech and Serum Institute to lower the price of their vaccine, COVAXIN, and Covishield as the Indian government has given the…
Left politics over vaccine prices
SII lifts up the prices. Pune based SII(Serum Institute India), on 21st April announced an increase in the Covishield prices. "The price rose to 400/- for the State governments and…